P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)

P&K Skin Research Center Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Operating Revenue	17,847	14,843	17,957
Other Revenue	-0	-	-
Revenue	17,847	14,843	17,957
Revenue Growth (YoY)	20.24%	-17.34%	-
Cost of Revenue	9,409	7,668	6,865
Gross Profit	8,438	7,175	11,092
Selling, General & Admin	3,828	3,918	3,428
Research & Development	1,519	1,357	1,670
Other Operating Expenses	23.15	29.3	19.82
Operating Expenses	5,856	5,796	5,452
Operating Income	2,582	1,379	5,640
Interest Expense	-26.49	-32.77	-25.77
Interest & Investment Income	3,753	3,808	2,215
Currency Exchange Gain (Loss)	0.86	-0.29	0.03
Other Non Operating Income (Expenses)	-224.19	63.36	546.89
EBT Excluding Unusual Items	6,085	5,217	8,377
Gain (Loss) on Sale of Investments	712.69	140.01	-185.18
Gain (Loss) on Sale of Assets	-0.31	-0	-0.97
Pretax Income	6,797	5,357	8,190
Income Tax Expense	1,097	656.54	1,060
Earnings From Continuing Operations	5,701	4,700	7,130
Minority Interest in Earnings	115.58	112.75	-
Net Income	5,816	4,813	7,130
Net Income to Common	5,816	4,813	7,130
Net Income Growth	20.84%	-32.50%	-
Shares Outstanding (Basic)	29	30	30
Shares Outstanding (Diluted)	29	30	30
Shares Change (YoY)	-3.32%	0.88%	-
EPS (Basic)	200.00	160.00	239.12
EPS (Diluted)	200.00	160.00	239.12
EPS Growth	25.00%	-33.09%	-
Free Cash Flow	8,410	4,023	6,277
Free Cash Flow Per Share	289.19	133.73	210.50
Dividend Per Share	-	-	35.000
Gross Margin	47.28%	48.34%	61.77%
Operating Margin	14.47%	9.29%	31.41%
Profit Margin	32.59%	32.43%	39.71%
Free Cash Flow Margin	47.12%	27.10%	34.96%
EBITDA	4,431	3,114	7,108
EBITDA Margin	24.83%	20.98%	39.59%
D&A For EBITDA	1,848	1,735	1,468
EBIT	2,582	1,379	5,640
EBIT Margin	14.47%	9.29%	31.41%
Effective Tax Rate	16.13%	12.26%	12.95%
Advertising Expenses	92.33	123.34	312.82

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.